Floxuridine
Metastatic Malignant Neoplasm in the Liver
ECOG-ACRIN Cancer Research GroupSmall moleculePhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
20 Active assets in the Metastatic Malignant Neoplasm in the Liver cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin ECOG-ACRIN Cancer Research Group | Phase 3 | BB |
Oxodotreotide Vanderbilt-Ingram Cancer Center | Phase 4 | B |
FLUOROURACILUM ECOG-ACRIN Cancer Research Group | Phase 3 | B |
Calcium folinate pentahydrate ECOG-ACRIN Cancer Research Group | Phase 3 | B |
Irinotecan ECOG-ACRIN Cancer Research Group | Phase 3 | B |
View all 29 →
Same molecule, other indications
Floxuridine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →